Mingqiang Fu

Dr. Mingqiang Fu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
PDF file
LPLei Pan
Lei Pan
MFMingqiang Fu
Mingqiang Fu
XTXiang-Lin Tang
Xiang-Lin Tang
YLYunlong Ling
Yunlong Ling
YSYangang Su
Yangang Su
JGJunbo Ge
Junbo Ge

20 April 2021 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
MFMingqiang Fu
Mingqiang Fu
SCShufu Chang
Shufu Chang
LGLei Ge
Lei Ge
DHDong Huang
Dong Huang
KYKang Yao
Kang Yao
JGJunbo Ge
Junbo Ge
Objective. The initial recanalization rate of coronary chronic total occlusions (CTOs) is >85 when performed by experienced operators, but only 10 of prior failed CTO patients receive reattempted recanalization. This retrospective study analyzed the success rate and strategies used in reattempt percutaneous coronary intervention (PCI) of CTOs after prior failures. Methods. Overall, 206 patients with 212 CTOs were enrolled. All patients with prior recanalization failures received reattempt PCIs from January 2015 to March 2019 at Zhongshan Hospital, Fudan University. Data on clinical factors (age, sex, comorbidities, left ventricular ejection fraction, history of cigarette usage, and revascularization), angiographic characteristics of CTOs (target lesion, Japanese Chronic Total Occlusion (J-CTO) score, the morphology of CTO lesions, and collateral channel scale), strategies (procedural approach and use of devices), and major adverse events were obtained and analyzed. Results. The mean age of enrolled patients was 60.96±12.36 years, with a male predominance of 90.3. Of the patients, 47.1 had a prior myocardial infarction and 70.4 underwent stent implantation previously, while the in-stent occlusion rate was 6.6. CTOs were primarily localized in the left anterior descending artery (43.9) and the right coronary artery (43.9). 80.7 of lesions were classified as very difficult (J-CTO score 3), and the overall success rate was 81.1. In multivariable regression analysis, J-CTO score, collateral channel scale, application of coronary multispiral computed tomography angiography, dual injection, intravascular ultrasound, active greeting technique, parallel wiring, and CTO morphology were predictors of recanalization success. There were no significant differences in rates of procedural complications between the final recanalization success and failure groups. Conclusions. Recanalization of complex CTOs is associated with high success rate and low complication rates when performed by high-volume CTO operators and after multiple reattempts.

1 March 2014 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
MFMingqiang Fu
Mingqiang Fu
JZJingmin Zhou
Jingmin Zhou
JXJianfeng Xu
Jianfeng Xu
HZHongmin Zhu
Hongmin Zhu
JLJianquan Liao
Jianquan Liao
JGJunbo Ge
Junbo Ge
Objective: To test whether olmesartan ameliorates cardiac diastolic dysfunction in spontaneously hypertensive rats (SHRs) through calcineurin pathway. Methods: Twenty-four male SHRs of 6 months were divided into saline- (n = 12) and olmesartan-treated (n = 12) groups. Age-matched WKY (n = 12) rats served as controls. Saline (10 mL·kg·d) or the same volume of olmesartan liquor (2.5 mg·kg·d) was administered by gavage for 3 months. Heart rate, systolic blood pressure, cardiac structure, and function and histological studies were determined. Expression of calcineurin and downstream NFAT3 were also detected. Results: Compared with age-matched Wistar Kyoto rats, SHRs of 6 months exhibited evident cardiac hypertrophy and diastolic dysfunction as demonstrated by elevated systolic blood pressure and E/E′, decreased E/A and E′/A′, while F, left ventricular ejection fraction and fractional shortening remained unimpaired. Treatment with olmesartan significantly decreased systolic blood pressure and ventricular hypertrophy, attenuated fibrosis, and improved diastolic function (all P < 0.05). Meanwhile, both calcineurin and NFAT3 expressions were downregulated in olmesartan group compared with the other 2 groups (both P < 0.05). Conclusions: These data suggest the beneficial effect of olmesartan on cardiac structure and diastolic dysfunction, and it may be mediated through calcineurin pathway. This indicates a new therapeutic target for diastolic dysfunction.